Floatz logo

LITHIUM, ELEMENTAL

Depression Not Otherwise Specified

Columbia Northwest PharmaceuticalsSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Depression Not Otherwise Specified cohort.

Asset / SponsorPhaseRating
Benserazide
New York State Psychiatric Institute
Phase 4BB
LEVODOPA
New York State Psychiatric Institute
Phase 4BB
Vortioxetine
Marianna Amboni
Phase 4BB
CITALOPRAM
Columbia Northwest Pharmaceuticals
Phase 2B

Same molecule, other indications

LITHIUM, ELEMENTAL is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
manic bipolar affective disorderDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar depressionDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →